These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 35324976)
1. Efficacy and safety of eplerenone treatment for patients with diabetic nephropathy: A meta-analysis. Hu H; Zhao X; Jin X; Wang S; Liang W; Cong X PLoS One; 2022; 17(3):e0265642. PubMed ID: 35324976 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Eplerenone for Treating Chronic Kidney Disease: A Meta-Analysis. Hu H; Cao M; Sun Y; Jin X; Zhao X; Cong X Int J Hypertens; 2023; 2023():6683987. PubMed ID: 36938116 [TBL] [Abstract][Full Text] [Related]
3. Xuebijing injection combined with alprostadil in the treatment of diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis. Hao N; Liu Y; Guo L; Li W; Zhao P Medicine (Baltimore); 2024 Jun; 103(24):e32095. PubMed ID: 38875385 [TBL] [Abstract][Full Text] [Related]
5. Spironolactone Add-on for Preventing or Slowing the Progression of Diabetic Nephropathy: A Meta-analysis. Hou J; Xiong W; Cao L; Wen X; Li A Clin Ther; 2015 Sep; 37(9):2086-2103.e10. PubMed ID: 26254276 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in diabetic nephropathy: a systematic review and meta-analysis. Du YH; Guan CJ; Li LY; Gan P Ann Palliat Med; 2022 Mar; 11(3):1093-1101. PubMed ID: 35365039 [TBL] [Abstract][Full Text] [Related]
8. The therapeutic effect and possible harm of puerarin for treatment of stage III diabetic nephropathy: a meta-analysis. Wang B; Chen S; Yan X; Li M; Li D; Lv P; Ti G Altern Ther Health Med; 2015; 21(1):36-44. PubMed ID: 25599431 [TBL] [Abstract][Full Text] [Related]
9. Meta-Analysis of the Efficacy and Safety of Finerenone in Diabetic Kidney Disease. Zheng Y; Ma S; Huang Q; Fang Y; Tan H; Chen Y; Li C Kidney Blood Press Res; 2022; 47(4):219-228. PubMed ID: 35034019 [TBL] [Abstract][Full Text] [Related]
10. Effects of Vitamin D Supplementation on Renal Function, Inflammation and Glycemic Control in Patients with Diabetic Nephropathy: a Systematic Review and Meta-Analysis. Wang Y; Yang S; Zhou Q; Zhang H; Yi B Kidney Blood Press Res; 2019; 44(1):72-87. PubMed ID: 30808855 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure). Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B; J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881 [TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of Buyang Huanwu Decoction for early-stage diabetic nephropathy: a Meta-analysis]. Zhao J; Mo C; Meng LF; Liang CQ; Cao X; Shi W Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1660-1667. PubMed ID: 31090332 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Sodium Tanshinone IIA Sulfonate Injection on Hypertensive Nephropathy: A Systematic Review and Meta-Analysis. Xu J; Zhang C; Shi X; Li J; Liu M; Jiang W; Fang Z Front Pharmacol; 2019; 10():1542. PubMed ID: 31920681 [No Abstract] [Full Text] [Related]
14. The effect of a methylxanthine vasodilator: pentoxifylline on the treatment of diabetic nephropathy-a meta-analysis. Zhang M; Wang Y; Fu W; Sun L Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2777-2791. PubMed ID: 37987795 [TBL] [Abstract][Full Text] [Related]
15. A Prospective Single-Blind Randomized Trial of Ramipril, Eplerenone and Their Combination in Type 2 Diabetic Nephropathy. El Mokadem M; Abd El Hady Y; Aziz A Cardiorenal Med; 2020; 10(6):392-401. PubMed ID: 32998143 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of tripterygium glycosides for diabetic nephropathy: a meta-analysis of randomized controlled trials. Guo HB; Peng JQ; Xuan Wang ; Zhang KK; Zhong GZ; Chen WH; Shi GX BMC Nephrol; 2021 Sep; 22(1):304. PubMed ID: 34493223 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of nonsteroidal mineralocorticoid receptor antagonists for renal and cardiovascular outcomes in patients with chronic kidney disease: a meta-analysis of randomized clinical trials. Chen Q; Wei G; Wang Y; Li X; Zhao Q; Zhu L; Xiao Q; Xiong X Front Pharmacol; 2024; 15():1338044. PubMed ID: 38476327 [No Abstract] [Full Text] [Related]
18. Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials. Shen X; Zhang Z; Zhang X; Zhao J; Zhou X; Xu Q; Shang H; Dong J; Liao L Lipids Health Dis; 2016 Oct; 15(1):179. PubMed ID: 27733168 [TBL] [Abstract][Full Text] [Related]
19. Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Hasegawa T; Nishiwaki H; Ota E; Levack WM; Noma H Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013109. PubMed ID: 33586138 [TBL] [Abstract][Full Text] [Related]
20. The Effects of Salvianolate Combined With Western Medicine on Diabetic Nephropathy: A Systematic Review and Meta-Analysis. Shen Y; Wang S; Liu Y; Ge L; Xia L; Zhang X; Miao Y; Shen J; Zhou Q Front Pharmacol; 2020; 11():851. PubMed ID: 32595500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]